In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

BACKGROUND: The increasing usage of statins (the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) has revealed a number of unexpected beneficial effects, including a reduction in cancer risk. METHODS: We investigated the direct anticancer effects of different statins approved for clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, P, Mukthavaram, R, Chao, Y, Nomura, N, Bharati, I S, Fogal, V, Pastorino, S, Teng, D, Cong, X, Pingle, S C, Kapoor, S, Shetty, K, Aggrawal, A, Vali, S, Abbasi, T, Chien, S, Kesari, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200085/
https://www.ncbi.nlm.nih.gov/pubmed/25093497
http://dx.doi.org/10.1038/bjc.2014.431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200085/
https://www.ncbi.nlm.nih.gov/pubmed/25093497
http://dx.doi.org/10.1038/bjc.2014.431

Ejemplares similares